458 related articles for article (PubMed ID: 3008706)
1. Characterization of stable Epstein-Barr (EB) virus transformed cell lines and mouse-human hybridomas producing a large quantity of anti-tetanus toxoid (TT) monoclonal antibody.
Minakawa H; Hirata Y; Sugawara I; Fukuda A; Yoshida TO
Behring Inst Mitt; 1985 Dec; (78):139-47. PubMed ID: 3008706
[TBL] [Abstract][Full Text] [Related]
2. Human anti-tetanus toxoid monoclonal antibody secreted by EBV-transformed human B cells fused with murine myeloma.
Kozbor D; Roder JC; Chang TH; Steplewski Z; Koprowski H
Hybridoma; 1982; 1(3):323-8. PubMed ID: 6092264
[TBL] [Abstract][Full Text] [Related]
3. Production of anti-tumor human monoclonal antibodies using different approaches.
Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
[TBL] [Abstract][Full Text] [Related]
4. A human hybrid hybridoma.
Tiebout RF; van Boxtel-Oosterhof F; Stricker EA; Zeijlemaker WP
J Immunol; 1987 Nov; 139(10):3402-5. PubMed ID: 3119707
[TBL] [Abstract][Full Text] [Related]
5. Human monoclonal antibody to purified protein derivative of tuberculin produced by hybrids constructed with Epstein-Barr virus-transformed B lymphocytes and mouse myeloma cells.
Garzelli C; Puglisi C; Falcone G
Eur J Immunol; 1986 May; 16(5):584-7. PubMed ID: 3009205
[TBL] [Abstract][Full Text] [Related]
6. A human hybrid myeloma for production of human monoclonal antibodies.
Kozbor D; Tripputi P; Roder JC; Croce CM
J Immunol; 1984 Dec; 133(6):3001-5. PubMed ID: 6092464
[TBL] [Abstract][Full Text] [Related]
7. In vitro stimulated lymphocytes as a source of human hybridomas.
Kozbor D; Roder JC
Eur J Immunol; 1984 Jan; 14(1):23-7. PubMed ID: 6319153
[TBL] [Abstract][Full Text] [Related]
8. Human lymphoblastoid cell line producing protective monoclonal IgG1, kappa anti-tetanus toxin.
Tiebout RF; Stricker EA; Hagenaars R; Zeijlemaker WP
Eur J Immunol; 1984 May; 14(5):399-404. PubMed ID: 6327321
[TBL] [Abstract][Full Text] [Related]
9. Human hybridomas constructed with antigen-specific Epstein-Barr virus-transformed cell lines.
Kozbor D; Lagarde AE; Roder JC
Proc Natl Acad Sci U S A; 1982 Nov; 79(21):6651-5. PubMed ID: 6292911
[TBL] [Abstract][Full Text] [Related]
10. Analysis of human monoclonal antibodies derived from lymphocytes of patients with cancer.
Cote RJ; Morrissey DM; Oettgen HF; Old LJ
Fed Proc; 1984 Jun; 43(9):2465-9. PubMed ID: 6327400
[TBL] [Abstract][Full Text] [Related]
11. SPAM-8, a mouse-human heteromyeloma fusion partner in the production of human monoclonal antibodies. Establishment of a human monoclonal antibody against cytomegalovirus.
Gustafsson B; Jondal M; Sundqvist VA
Hum Antibodies Hybridomas; 1991 Jan; 2(1):26-32. PubMed ID: 1651784
[TBL] [Abstract][Full Text] [Related]
12. [Study of anticancer human monoclonal antibody--establishment of human monoclonal antibody to gastric cancer by human-mouse hybridoma].
Liu H
Zhonghua Zhong Liu Za Zhi; 1988 Jul; 10(4):242-4. PubMed ID: 3248478
[TBL] [Abstract][Full Text] [Related]
13. Optimisation of human anti-tetanus toxoid antibody responses and location of human cells in SCID mice transplanted with human peripheral blood leucocytes.
Jackson DJ; Kumpel BM
Hum Antibodies; 1997; 8(4):181-8. PubMed ID: 9395920
[TBL] [Abstract][Full Text] [Related]
14. [Human monoclonal antibodies with human-mouse hybridomas].
Naoe T; Kato K; Shiku H; Yamada K
Gan To Kagaku Ryoho; 1983 Dec; 10(12):2575-81. PubMed ID: 6606396
[TBL] [Abstract][Full Text] [Related]
15. Pokeweed mitogen-stimulated human lymphocytes fused to LICR-2 (HMY2) generate human-human hybridomas producing monoclonal IgG antibodies reactive to human breast carcinoma and malignant melanoma.
Martin RF; Kisor R; Schroer D; Eichler G; Filaccio ML
Hum Antibodies Hybridomas; 1990; 1(3):154-9. PubMed ID: 2103359
[TBL] [Abstract][Full Text] [Related]
16. Generation of human anti-rubella monoclonal antibodies from human hybridomas constructed with antigen-specific Epstein-Barr virus transformed cell lines.
Hilfenhaus J; Kanzy EJ; Köhler R; Willems WR
Behring Inst Mitt; 1986 Jun; (80):31-41. PubMed ID: 3019293
[TBL] [Abstract][Full Text] [Related]
17. Characterization of mouse-human hybridoma as a useful fusion partner for the establishment of mouse-human-human hybridoma secreting anti-tetanus toxoid human monoclonal antibody of IgM or IgG class.
Hirata Y; Sugawara I
Microbiol Immunol; 1987; 31(3):231-45. PubMed ID: 3613992
[TBL] [Abstract][Full Text] [Related]
18. Experiences in the production of human monoclonal antibodies to tetanus toxoid.
Boyd JE; Hastings I; Farzad Z; James K; McClelland DB
Dev Biol Stand; 1984; 57():93-8. PubMed ID: 6526155
[TBL] [Abstract][Full Text] [Related]
19. Production of mouse monoclonal antibodies against human HLA-A3 for use in microlymphocytotoxicity technique.
Yari F; Sareh S; Sadri A; Sharifi Z; Najafi F
Hum Antibodies; 2009; 18(3):119-22. PubMed ID: 19729806
[TBL] [Abstract][Full Text] [Related]
20. Isolation of human monoclonal antibodies binding to B fragment of diphtheria toxin.
Gupta KC; Agha R; Santos E; Brodeur BR
Hum Antibodies Hybridomas; 1992 Jan; 3(1):25-31. PubMed ID: 1576320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]